Rybelsus Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Semaglutide

Indications/Uses

Adjunct to diet & exercise in adults w/ insufficiently controlled type 2 DM to improve glycaemic control as monotherapy when metformin is inappropriate due to intolerance or contraindications; in combination w/ other medicinal products for diabetes.

Dosage/Direction for Use

Initially 3 mg once daily for 1 mth. Maintenance dose: Increase to 7 mg once daily after 1 mth & may be increased further to 14 mg once daily after at least 1 mth to improve glycaemic control. Max single daily dose: 14 mg.

Administration

Should be taken on an empty stomach: Wait at least 30 min before eating/drinking/taking other oral medicinal products. Swallow whole w/ sip of water. Do not split/crush/chew.

Contraindications

Hypersensitivity.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BJ06 - semaglutide ; Belongs to the class of glucagon-like peptide-1 (GLP-1) analogues. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Rybelsus tab 14 mg

Packing/Price

1's

Form

Rybelsus tab 3 mg

Packing/Price

1's

Form

Rybelsus tab 7 mg

Packing/Price

1's

Rybelsus

semaglutide

Manufacturer:

Novo Nordisk A/S